DK1154795T3 - Middel til behandling af diagnosticering af restless legs syndrom - Google Patents

Middel til behandling af diagnosticering af restless legs syndrom

Info

Publication number
DK1154795T3
DK1154795T3 DK99957453T DK99957453T DK1154795T3 DK 1154795 T3 DK1154795 T3 DK 1154795T3 DK 99957453 T DK99957453 T DK 99957453T DK 99957453 T DK99957453 T DK 99957453T DK 1154795 T3 DK1154795 T3 DK 1154795T3
Authority
DK
Denmark
Prior art keywords
cei
sleep
restless legs
legs syndrome
agonist
Prior art date
Application number
DK99957453T
Other languages
English (en)
Inventor
Jan Hedner
Holger Kraiczi
Original Assignee
Jan Hedner
Holger Kraiczi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Hedner, Holger Kraiczi filed Critical Jan Hedner
Application granted granted Critical
Publication of DK1154795T3 publication Critical patent/DK1154795T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Advance Control (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99957453T 1998-11-04 1999-11-03 Middel til behandling af diagnosticering af restless legs syndrom DK1154795T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803760A SE9803760D0 (sv) 1998-11-04 1998-11-04 Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel

Publications (1)

Publication Number Publication Date
DK1154795T3 true DK1154795T3 (da) 2006-01-02

Family

ID=20413169

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99957453T DK1154795T3 (da) 1998-11-04 1999-11-03 Middel til behandling af diagnosticering af restless legs syndrom

Country Status (7)

Country Link
EP (1) EP1154795B1 (da)
AT (1) ATE302025T1 (da)
DE (1) DE69926804T2 (da)
DK (1) DK1154795T3 (da)
ES (1) ES2251242T3 (da)
SE (1) SE9803760D0 (da)
WO (1) WO2000025821A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
RS50070B (sr) 1997-12-22 2009-01-22 Euro-Celtique S.A., Oralni dozni oblik sa kombinacijom opijatnog agonista i antagonista
DE19938823A1 (de) * 1999-08-19 2001-02-22 Boehringer Ingelheim Pharma Medikamentöse Behandlung des Restless Leg Syndroms
JP4453254B2 (ja) 2001-03-30 2010-04-21 東レ株式会社 レストレス・レッグズ症候群治療薬
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
ES2546010T3 (es) 2002-04-05 2015-09-17 Euro-Celtique S.A. Preparación farmacéutica que contiene oxicodona y naloxona
US6960571B2 (en) 2003-03-14 2005-11-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
EP1653971A2 (en) * 2003-08-13 2006-05-10 Janssen Pharmaceutica N.V. Treatment of sleep disorders with cholinesterase inhibitors
EP1689704A2 (en) 2003-10-21 2006-08-16 CoLucid Pharmaceuticals, Inc. Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
WO2005079851A2 (en) * 2004-02-18 2005-09-01 Sepracor, Inc. Dopamine-agonist combination therapy with sedatives for improving sleep quality
EP1604667A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the restless leg syndrome
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
EP1891946A1 (en) * 2006-08-14 2008-02-27 Santhera Pharmaceuticals (Schweiz) AG Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone
WO2008097546A2 (en) 2007-02-02 2008-08-14 Colucid Pharmaceuticals, Inc. Compounds that inhibit cholinesterase
US20090048229A1 (en) * 2007-07-18 2009-02-19 Rupniak Nadia M J Methods for promoting wakefulness
TR201900199T4 (tr) 2009-03-10 2019-02-21 Euro Celtique Sa Oksikodon ve nalokson içeren çabuk salımlı farmasötik bileşimler.
EP2251010A1 (en) 2009-05-08 2010-11-17 Sygnis Bioscience GmbH & Co. KG Use of thiabendazole and derivatives thereof for the therapy of neurological conditions
CA2790164A1 (en) 2010-02-17 2011-08-25 Sun Pharma Advanced Research Company Ltd. Method of treating a disease condition susceptible to baclofen therapy
UA116567C2 (uk) 2013-07-23 2018-04-10 Євро-Селтік С.А. Комбінація оксикодону та налоксону для застосування в лікуванні болю у пацієнтів, які страждають від болю та захворювання, що призводить до дисбактеріозу кишечнику та/або підвищує ризик кишкової бактеріальної транслокації

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO274596A0 (en) * 1996-10-04 1996-10-31 Armstrong, Stuart Maxwell Method for the treatment of neurological or neuropsychiatric disorders
DE19701619B4 (de) * 1997-01-17 2007-10-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Pramipexol zur Behandlung des restless legs syndroms

Also Published As

Publication number Publication date
EP1154795B1 (en) 2005-08-17
ATE302025T1 (de) 2005-09-15
EP1154795A1 (en) 2001-11-21
WO2000025821A1 (en) 2000-05-11
ES2251242T3 (es) 2006-04-16
DE69926804D1 (de) 2005-09-22
DE69926804T2 (de) 2006-06-22
SE9803760D0 (sv) 1998-11-04

Similar Documents

Publication Publication Date Title
DK1154795T3 (da) Middel til behandling af diagnosticering af restless legs syndrom
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
CY1107452T1 (el) Διαδερμικη μορφη χορηγησης για τη θεραπεια του συνδρομου ανησυχων ποδιων
DE60101201D1 (de) Verwendung von nikotinergen acetylcholinrezeptor-agonisten zur herstellung eines medikaments zur behandlung von keratoconjuctivitis sicca
DK0668863T3 (da) Quinuclidinderivat som substans P-antagonist
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
DE69738615D1 (de) Verwendung von glp-1 oder analogen zur behandlung von myokardischem infarkt
BR0308904A (pt) Método de tratamento de gastroparesia, e, uso de um composto de glp-1
NO20073831L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
HUP0401590A2 (hu) Eljárások allogén sziget átültetés védelmére oldható CTLA4 mutáns molekulák alkalmazásával
ATE320257T1 (de) (s,s)-reboxetine zur behandlung chronischer schmerzen
DK1742624T3 (da) Dopamin-agonist-kombinationsterapi med sedativer til forbedring af søvnkvalitet
HUP0202570A1 (hu) Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk
ATE431141T1 (de) Zusammensetzungen und verfahren zur behandlung der parkinson-krankheit
NO20043013L (no) Tetrahydrokinolin analoger som muskarine agonister
HUP0401501A2 (hu) Érrendszeri gyulladás kezelése vagy megelőzése szterin-felszívódást gátló anyagokat tartalmazó gyógyszerkészítmények alkalmazásával
NO990522D0 (no) Anvendelse av <beta>-ark mimetika som protease- og kinaseinhibatorer av transkripsjonsfaktorer
DK1296972T3 (da) Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer
IN2005KO00312A (da)
DK0946162T3 (da) Anvendelse af p-aminophenol-derivater til fremstilling af farmaceutiske præparater, som er nyttige til behandlingen af neurodegenerative sygdomme
ATE271861T1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
DE69822810D1 (de) Somatostatin und somatostatin agoniste zur behandlung der insulinsunempfindlichkeit und syndrome x
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
NO20075831L (no) Krystallinske faste og amorfe former av (-)- halofenat
DE60121978D1 (de) 7-CHLOR-4-HYDROXY-2-(2-PYRIDYLETHYL)-1,2,5,10-TETRAHYDROPYRIDAZINOi4,5-BöCHINOLIN-1,10-DIONE UND IHRE VERWENDUNG ZUR BEHANDLUNG VON SCHMERZEN